Literature DB >> 11567096

Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1.

B A Hofmann1, S Sydow, O Jahn, L van Werven, T Liepold, K Eckart, J Spiess.   

Abstract

Rat corticotropin-releasing factor receptor 1 (rCRFR1) was produced either in transfected HEK 293 cells as a complex glycosylated protein or in the presence of the mannosidase I inhibitor kifunensine as a high mannose glycosylated protein. The altered glycosylation did not influence the biological function of rCRFR1 as demonstrated by competitive binding of rat urocortin (rUcn) or human/rat corticotropin-releasing factor (h/rCRF) and agonist-induced cAMP accumulation. The low production rate of the N-terminal domain of rCRFR1 (rCRFR1-NT) by transfected HEK 293 cells, was increased by a factor of 100 in the presence of kifunensine. The product, rCRFR1-NT-Kif, bound rUcn specifically (K(D) = 27 nM) and astressin (K(I) = 60 nM). This affinity was 10-fold lower than the affinity of full length rCRFR1. However, it was sufficiently high for rCRFR1-NT-Kif to serve as a model for the N-terminal domain of rCRFR1. With protein fragmentation, Edman degradation, and mass spectrometric analysis, evidence was found for the signal peptide cleavage site C-terminally to Thr(23) and three disulfide bridges between precursor residues 30 and 54, 44 and 87, and 68 and 102. Of all putative N-glycosylation sites in positions 32, 38, 45, 78, 90, and 98, all Asn residues except for Asn(32) were glycosylated to a significant extent. No O-glycosylation was observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567096      PMCID: PMC2374224          DOI: 10.1110/ps.12101

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  57 in total

1.  Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.

Authors:  D A Myers; J V Trinh; T R Myers
Journal:  Mol Cell Endocrinol       Date:  1998-09-25       Impact factor: 4.102

2.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.

Authors:  J L Mellquist; L Kasturi; S L Spitalnik; S H Shakin-Eshleman
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

4.  Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri.

Authors:  M R Palchaudhuri; R L Hauger; S Wille; E Fuchs; F M Dautzenberg
Journal:  J Neuroendocrinol       Date:  1999-06       Impact factor: 3.627

5.  Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

Authors:  M Perrin; C Donaldson; R Chen; A Blount; T Berggren; L Bilezikjian; P Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary.

Authors:  E Potter; S Sutton; C Donaldson; R Chen; M Perrin; K Lewis; P E Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Molecular Properties of the CRF Receptor.

Authors:  J Spiess; F M Dautzenberg; S Sydow; R L Hauger; A Rühmann; T Blank; J Radulovic
Journal:  Trends Endocrinol Metab       Date:  1998 May-Jun       Impact factor: 12.015

8.  Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function.

Authors:  T M Savarese; C D Wang; C M Fraser
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

9.  Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.

Authors:  M H Perrin; S W Sutton; L A Cervini; J E Rivier; W W Vale
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

10.  Cloning and characterization of human urocortin.

Authors:  C J Donaldson; S W Sutton; M H Perrin; A Z Corrigan; K A Lewis; J E Rivier; J M Vaughan; W W Vale
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more
  11 in total

1.  Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a.

Authors:  Jana Klose; Norbert Wendt; Sybille Kubald; Eberhard Krause; Klaus Fechner; Michael Beyermann; Michael Bienert; Rainer Rudolph; Sven Rothemund
Journal:  Protein Sci       Date:  2004-08-04       Impact factor: 6.725

2.  NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor.

Authors:  Christy R R Grace; Marilyn H Perrin; Michael R DiGruccio; Charleen L Miller; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

3.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

Review 4.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

5.  The signal peptide of the rat corticotropin-releasing factor receptor 1 promotes receptor expression but is not essential for establishing a functional receptor.

Authors:  Martina Alken; Claudia Rutz; Robert Köchl; Ute Donalies; Morad Oueslati; Jens Furkert; Doreen Wietfeld; Ricardo Hermosilla; Anne Scholz; Michael Beyermann; Walter Rosenthal; Ralf Schülein
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 6.  Emerging role of alternative splicing of CRF1 receptor in CRF signaling.

Authors:  Michał A Zmijewski; Andrzej T Slominski
Journal:  Acta Biochim Pol       Date:  2010-03-16       Impact factor: 2.149

7.  Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1).

Authors:  Iman Assil-Kishawi; Tareq A Samra; Dale F Mierke; Abdul B Abou-Samra
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

8.  Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.

Authors:  Hossein Tezval; Olaf Jahn; Cedomir Todorovic; Astrid Sasse; Klaus Eckart; Joachim Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 9.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

10.  Expression and functional characterization of membrane-integrated mammalian corticotropin releasing factor receptors 1 and 2 in Escherichia coli.

Authors:  Roberto Jappelli; Marilyn H Perrin; Kathy A Lewis; Joan M Vaughan; Christos Tzitzilonis; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.